Correlation Between Imugene and Anatara Lifesciences

Can any of the company-specific risk be diversified away by investing in both Imugene and Anatara Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Imugene and Anatara Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Imugene and Anatara Lifesciences, you can compare the effects of market volatilities on Imugene and Anatara Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Imugene with a short position of Anatara Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Imugene and Anatara Lifesciences.

Diversification Opportunities for Imugene and Anatara Lifesciences

0.59

Correlation Coefficient

Imugene  Anatara Lifesciences

Very weak diversification

The 3 months correlation between Imugene and Anatara is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Imugene and Anatara Lifesciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anatara Lifesciences and Imugene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Imugene are associated (or correlated) with Anatara Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anatara Lifesciences has no effect on the direction of Imugene i.e., Imugene and Anatara Lifesciences go up and down completely randomly.

Pair Corralation between Imugene and Anatara Lifesciences

Assuming the 90 days trading horizon Imugene is expected to generate 0.38 times more return on investment than Anatara Lifesciences. However, Imugene is 2.64 times less risky than Anatara Lifesciences. It trades about -0.01 of its potential returns per unit of risk. Anatara Lifesciences is currently generating about -0.15 per unit of risk. If you would invest  3.60  in Imugene on December 30, 2024 and sell it today you would lose (0.30) from holding Imugene or give up 8.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Imugene  vs.  Anatara Lifesciences

Imugene

Risk-Adjusted Performance

Very Weak

Over the last 90 days Imugene has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Imugene is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Anatara Lifesciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Anatara Lifesciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Imugene and Anatara Lifesciences

The main advantage of trading using opposite Imugene and Anatara Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Imugene position performs unexpectedly, Anatara Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anatara Lifesciences will offset losses from the drop in Anatara Lifesciences' long position.

The idea behind Imugene and Anatara Lifesciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.